301075 多瑞醫藥
按盤價 
45.420 +1.020 (+2.297%)
45.420 +1.020 (+2.297%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -6.484 | -8.651 | 2.475 | 2.655 | 13.235 |
| 總資產報酬率 ROA (%) | -2.847 | -4.807 | 1.913 | 2.343 | 11.208 |
| 投入資產回報率 ROIC (%) | -4.186 | -6.293 | 2.074 | 2.449 | 12.454 | 邊際利潤分析 |
| 銷售毛利率 (%) | 4.072 | 42.415 | 68.552 | 76.981 | 88.608 |
| 營業利潤率 (%) | -54.955 | -35.641 | 6.637 | 5.300 | 13.860 |
| 息稅前利潤/營業總收入 (%) | -46.959 | -34.305 | 5.295 | 3.316 | 13.853 |
| 淨利潤/營業總收入 (%) | -56.165 | -35.335 | 5.113 | 4.634 | 12.436 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 114.007 | 87.826 | 16.708 | 59.917 | 86.991 |
| 價值變動淨收益/利潤總額(%) | -1.639 | -6.847 | 25.662 | 0.054 | -0.268 |
| 營業外收支淨額/利潤總額(%) | 0.266 | 0.010 | 0.277 | -1.101 | -0.170 | 償債能力分析 |
| 流動比率 (X) | 1.240 | 1.238 | 5.024 | 4.478 | 11.611 |
| 速動比率 (X) | 1.132 | 1.148 | 4.767 | 4.252 | 11.455 |
| 資產負債率 (%) | 52.007 | 50.913 | 23.370 | 16.182 | 7.375 |
| 帶息債務/全部投入資本 (%) | 23.452 | 21.298 | 19.278 | 12.196 | 2.961 |
| 股東權益/帶息債務 (%) | 270.480 | 308.203 | 416.939 | 719.075 | 3,277.070 |
| 股東權益/負債合計 (%) | 84.066 | 86.592 | 308.101 | 516.675 | 1,262.815 |
| 利息保障倍數 (X) | -5.767 | -25.609 | -3.893 | -1.722 | 836.483 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 176.955 | 136.615 | 91.088 | 84.255 | 67.179 |
| 存貨周轉天數 (天) | 83.696 | 102.593 | 112.825 | 83.045 | 73.544 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 29/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
